2023-01-25 09:10:00

Implantica has successfully completed ISO 13485 and MDSAP recertifications

Logo PR Newswire
PR Newswire

VADUZ, Liechtenstein, Jan. 25, 2023 /PRNewswire/ -- Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, announces that after a successful recertification audit program, Implantica CE Reflux Ltd. has obtained renewed ISO 13485 Quality Management System (QMS) and Medical Device Single Audit Program (MDSAP) certificates from its notified body, BSI.

The ISO 13485 recertification demonstrates that Implantica's quality management system complies with the recognized international standard for the design, development and distribution of medical devices, and the MDSAP recertification supports a medical device manufacturer's quality management system to satisfy the requirements of multiple regulatory authorities.

"These recertifications provide the necessary foundation for building the continued commercial success of RefluxStop™, our CE-marked implant that treats the cause of acid reflux and is designed to become the standard of care in a market with 1 billion sufferers. The entire process confirms the high compliance and regulatory standard that Implantica maintains and is a key achievement. Congratulations to the entire team at Implantica for their dedication and commitment to maintaining the highest level of quality standards and patient safety across the company," says Peter Forsell, CEO of Implantica.

For further information, please contact:
Nicole Pehrsson, Chief Corporate Affairs Officer
Telephone (CH): +41 (0)79 335 09 49
nicole.pehrsson@implantica.com

Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm.

The company's Certified Adviser is FNCA Sweden AB, info@fnca.se

The information was sent for publication, through the agency of the contact person set out above, on January 25, 2023, at 8:30 a.m. CET.

About Implantica

Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica's lead product, RefluxStop™, is a CE-marked implant for the prevention of gastroesophageal reflux that has the potential to create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energising platform designed to power remote controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit www.implantica.com for further information.

Newsroom

https://www.implantica.com/media/media-kit

ISO 13485 certificate

https://implantica.prod.waas.site/files/MD660600.pdf

MDSAP certificate

https://implantica.prod.waas.site/files/MDSAP709255.pdf

Product Pipeline

https://www.implantica.com/product-pipeline/prioritized-products/

Technology Platform

https://www.implantica.com/innovations/technology-platform-overview/

Media Contact:
Implantica AG
Juanita Eberhart
VP Marketing
M: +1 925-381-4581
juanita.eberhart@implantica.com

The following files are available for download:

Cision View original content:https://www.prnewswire.co.uk/news-releases/implantica-has-successfully-completed-iso-13485-and-mdsap-recertifications-301730175.html

Logo PR Newswire
TechnologyPress Release2023-01-24 14:00:00
TetraScience proves adherence to information security best practices through an independent audit BOSTON, Jan. 24, 2023 /PRNewswire/ -- TetraScience, the...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-24 15:05:00
Successful completion underscores continuing commitment to providing data-secure solutions ReposiTrak, the largest network of food supply chain operators...

Logo PR Newswire
TechnologyPress Release2023-01-24 13:00:00
Expanded partnership to deliver high-quality, affordable care to members wherever they are TROY, N.Y., Jan. 24, 2023 /PRNewswire/ -- UCM Digital Health...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-24 12:36:00
Treatment IDE Will Provide Opportunity to Treat Additional Patients in the US SAN RAMON, Calif., Jan. 24, 2023 /PRNewswire/ -- BioVentrix, Inc., a privately...

Logo PR Newswire
HealthPress Release2023-01-24 12:36:00
Treatment IDE Will Provide Opportunity to Treat Additional Patients in the US SAN RAMON, Calif., Jan. 24, 2023 /PRNewswire/ -- BioVentrix ®, Inc., a...

Logo EIN Presswire
TechnologyPress Release2023-01-24 14:11:07
CARROLLTON,, TEXAS, UNITED STATES, January 24, 2023 / EINPresswire.com / -- CodeBot for SAP SuccessFactors is delighted to announce their renewal of the ISO...

Logo GlobeNewswire
SciencePress Release2023-01-24 21:01:00
CAMBRIDGE, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through barriers...

Logo PR Newswire
HealthPress Release2023-01-24 13:44:00
MIAMI, Jan. 24, 2023 /PRNewswire/ -- Opus EHR., a leading cloud-based electronic health record (EHR) platform is pleased to announce a strategic partnership...

Logo PR Newswire
AHMEDABAD, India, Jan. 24, 2023 /PRNewswire/ -- Prudent Corporate Advisory Services Limited (Prudent), a Gujarat-based independent retail wealth management...

Logo EIN Presswire
OLOID achieves AICPA SOC2 Type II certification OLOID Inc., a leading provider of identity and access management solutions to the modern workplace, announced...

Logo GlobeNewswire
TechnologyPress Release2023-01-24 16:00:00
Accreditation Recognizes Kandous Commitment to Quality, Operational Excellence and Customer Satisfaction SAINT-SULPICE, Switzerland, Jan. 24, 2023 (GLOBE...

Logo PR Newswire
HealthPress Release2023-01-24 13:05:00
ALTSTAETTEN, Switzerland, Jan. 24, 2023 /PRNewswire/ -- icotec ag, the leading medical device manufacturer of Carbon/PEEK spinal implants, announces the U.S....

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-24 11:00:00
MedAllies National HISP will provide embedded Clinical Direct Messaging for Expanse MaaS EHR Platform FISHKILL, N.Y., Jan. 24, 2023 /PRNewswire-PRWeb/...

Logo PR Newswire
HealthPress Release2023-01-24 12:17:00
Emerging Market Leader Continues to Execute on Successful Growth Strategy JACKSONVILLE, Fla., Jan. 24, 2023 /PRNewswire/ -- ReviveHealth, a whole health and...

Logo PR Newswire
LOS ANGELES, Jan. 24, 2023 /PRNewswire/ -- iVision Mobile, a leading provider of white label mobile marketing software, announced today the completion of its...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-24 10:00:00
ATUM, a global specialist and industry leader in bioengineering solutions, today announced the signing of a full licensing agreement for the Leap-In...

Logo GlobeNewswire
SciencePress Release2023-01-24 14:00:00
CARLSBAD, Calif., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Qualigen or the Company, Nasdaq: QLGN), a diversified life sciences company...

Logo PR Newswire
DUBLIN, Jan. 24, 2023 /PRNewswire/ -- The "Saudi Arabia Dental Implants Market, By Material (Titanium v/s Zirconium), By Design (Tapered v/s...

Logo GlobeNewswire
SciencePress Release2023-01-24 13:00:00
BOSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on central nervous system (CNS)...

Logo PR Newswire
TechnologyPress Release2023-01-23 20:50:00
Opus Interactive, leading cloud hosting and colocation solutions provider, today announced that it has achieved ISO/IEC 27001:2013 certification for its...